Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2
Clinical trial NCT04345900 · COMPLETED
Trial details
- NCT number
- NCT04345900
- Sponsor
- BeyondSpring Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-05
- Primary completion
- 2018-03-20
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.